Skip to main content

Table 3 ACT† prescription according to tests results, and clinical malaria* in pre- and post-RDT implementation areas

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

  Ifakara HDSS (pre- RDT implementation) Rufiji HDSS (post- RDT implementation) P-value
  n/N %(95% CI) n/N %(95% CI)  
RDT positive 22/30 73.3 (53.1-87.0) 79/95 83.2 (69.2-91.6) 0.32
RDT negative 28/104 26.9 (16.4-40.9) 17/217 7.8 (4.7-12.7) <0.01
Microscopy positive 62/110 56.4 (41.5-70.1) 15/36 41.7 (22.1-64.3) 0.28
Microscopy negative 7/135 5.2 (2.1-12.1) 5/96 5.2 (2.3-11.6) 0.99
Clinical diagnosis of malaria and no diagnostic test performed 165/313 52.7 (42.9-62.4) 99/220 45.0 (34.3-56.2) 0.33
No clinical diagnosis of malaria and no diagnostic test performed 7/94 7.5 (2.9-15.8) 2/49 4.1 (1.1-14.4) 0.45
  1. * Clinical diagnosis of malaria based on presence of fever in patients who did not receive a malaria diagnostic test † = Artemether lumefantrine.